Physician profile
James M Tucker
NPI 1841332970
$982.01
in general payments reported to CMS, 2019-2025
11 companies · $666 in 2025
The $666 reported for 2025 was more than what 91% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.50 · 2021: $56.20 · 2023: $125 · 2024: $121 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.31 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $250.00 | 2025 | Myosure Tissue Removal Device |
| Baxter Healthcare | $150.00 | 2025 | Seprafilm |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Smith+Nephew, INC. | $110.14 | 2025 | Pico 7 |
| Innovation Technologies INC | $106.83 | 2024 | Irrisept |
| Integra Lifesciences Corporation | $105.16 | 2025 | Tenoglide |
| Abbvie INC. | $56.20 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.54 | 2024-2025 | Fruzaqla |
| Sage Therapeutics, LLC | $13.82 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $13.82 | 2025 | Qelbree |
| Allergan, INC. | $13.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.